Clinical Trials Directory

Trials / Unknown

UnknownNCT03803930

Comparing of a 22G EUS Procore Fine Needle Biopsy Device and a 20G EUS Procore Fine Needle Biopsy Device

Comparing of a 22G EUS Procore Fine Needle Biopsy Device and a 20G EUS Procore Fine Needle Biopsy Device for Solid Pancreatic Lesions: a Prospective Multi-center, Randomized, and Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
1,224 (estimated)
Sponsor
Huazhong University of Science and Technology · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the diagnosis accuracy of 22G EUS Procore fine needle biopsy (FNB)device and 20G EUS Procore fine needle biopsy device for solid pancreatic lesions.

Detailed description

This is a single-blind, randomized, controlled trial. One thousand two hundred and twenty four patients with solid pancreatic lesions referred for EUS guided fine needle biopsy will be randomly assigned to 4 arms. For arm A1 which will be used with 22G EUS Procore fine needle biopsy device, the pass sequence is slow pull(SP)-modified wet suction technique(MWST)-slow pull(SP)-modified wet suction technique(MWST). For arm A2 with 22G EUS Procore fine needle biopsy device, the pass sequence is MWST-SP-MWST-SP. For arm B1 with 20G EUS Procore fine needle biopsy device, the pass sequence is SP-MWST-SP-MWST. For arm B2 with 20G EUS Procore fine needle biopsy device, the pass sequence is MWST-SP-MWST-SP. All procedures will be performed by experienced echoendoscopists, and the patients and assessors (cytologists and pathologists) will be blinded during the entire study. The primary outcome measure is the diagnosis yield. Secondary outcome measures are specimen quality.

Conditions

Interventions

TypeNameDescription
DEVICEUsing 22G FNB, the first pass is SPUsing 22G FNB, the first pass is SP and the pass sequence is SP-MWST-SP-MWST.
DEVICEUsing 22G FNB, the first pass is MWSTUsing 22G FNB, the first pass is MWST and the pass sequence is MWST-SP-MWST-SP.
DEVICEUsing 20G FNB, the first pass is SPUsing 20G FNB, the first pass is SP and the pass sequence is SP-MWST-SP-MWST.
DEVICEUsing 20G FNB, the first pass is MWSTUsing 20G FNB, the first pass is MWST and the pass sequence is MWST-SP-MWST-SP.technique-slow pull.

Timeline

Start date
2019-03-01
Primary completion
2020-06-01
Completion
2020-08-01
First posted
2019-01-15
Last updated
2019-01-17

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03803930. Inclusion in this directory is not an endorsement.